Ryan Specialty Holdings, Inc. (NYSE:RYAN – Get Free Report) Director Nicholas Dominic Cortezi sold 35,000 shares of the company’s stock in a transaction on Monday, January 27th. The shares were sold at an average price of $65.25, for a total transaction of $2,283,750.00. Following the sale, the director now directly owns 6,209 shares in the company, valued at approximately $405,137.25. The trade was a 84.93 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Nicholas Dominic Cortezi also recently made the following trade(s):
- On Thursday, January 23rd, Nicholas Dominic Cortezi sold 10,485 shares of Ryan Specialty stock. The shares were sold at an average price of $65.12, for a total transaction of $682,783.20.
- On Tuesday, January 21st, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $66.35, for a total transaction of $2,322,250.00.
- On Friday, January 17th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $67.15, for a total transaction of $2,350,250.00.
- On Wednesday, January 15th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $65.99, for a total transaction of $2,309,650.00.
- On Monday, January 13th, Nicholas Dominic Cortezi sold 29,466 shares of Ryan Specialty stock. The stock was sold at an average price of $65.06, for a total transaction of $1,917,057.96.
- On Friday, December 20th, Nicholas Dominic Cortezi sold 91 shares of Ryan Specialty stock. The stock was sold at an average price of $65.00, for a total transaction of $5,915.00.
- On Wednesday, December 18th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $65.17, for a total transaction of $2,280,950.00.
- On Monday, December 16th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $66.71, for a total transaction of $2,334,850.00.
- On Friday, December 13th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $67.39, for a total transaction of $2,358,650.00.
Ryan Specialty Stock Performance
Shares of NYSE:RYAN traded up $0.25 during trading on Tuesday, hitting $65.61. 1,328,999 shares of the stock traded hands, compared to its average volume of 1,047,870. The company has a fifty day moving average price of $67.14 and a two-hundred day moving average price of $66.40. Ryan Specialty Holdings, Inc. has a 52-week low of $42.21 and a 52-week high of $75.97. The company has a market cap of $17.18 billion, a price-to-earnings ratio of 85.20, a P/E/G ratio of 1.14 and a beta of 0.72. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40.
Ryan Specialty Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were paid a $0.11 dividend. The ex-dividend date was Tuesday, November 12th. This represents a $0.44 dividend on an annualized basis and a yield of 0.67%. Ryan Specialty’s dividend payout ratio is currently 57.14%.
Analyst Upgrades and Downgrades
A number of analysts have recently weighed in on the stock. Keefe, Bruyette & Woods lowered their price target on shares of Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating on the stock in a report on Friday, January 10th. Bank of America lifted their target price on shares of Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a research note on Thursday, October 10th. Wells Fargo & Company lowered their target price on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 14th. Barclays lifted their target price on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, November 21st. Finally, Morgan Stanley began coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They set an “overweight” rating and a $90.00 price target for the company. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $74.40.
Check Out Our Latest Stock Report on RYAN
Institutional Investors Weigh In On Ryan Specialty
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Hollencrest Capital Management purchased a new stake in Ryan Specialty in the 3rd quarter valued at about $25,000. Assetmark Inc. purchased a new stake in Ryan Specialty in the 3rd quarter valued at about $34,000. Quarry LP increased its stake in Ryan Specialty by 109.3% during the third quarter. Quarry LP now owns 808 shares of the company’s stock worth $54,000 after purchasing an additional 422 shares during the period. GAMMA Investing LLC increased its stake in Ryan Specialty by 106.4% during the third quarter. GAMMA Investing LLC now owns 1,249 shares of the company’s stock worth $83,000 after purchasing an additional 644 shares during the period. Finally, Signaturefd LLC increased its stake in Ryan Specialty by 12.3% during the third quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock worth $89,000 after purchasing an additional 148 shares during the period. Institutional investors and hedge funds own 84.82% of the company’s stock.
About Ryan Specialty
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Further Reading
- Five stocks we like better than Ryan Specialty
- What Does Downgrade Mean in Investing?
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- What Does the Future Hold for Eli Lilly?
- The Significance of Brokerage Rankings in Stock Selection
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.